SETD4 and cancer: Furthermore, we examined the condition of neoantigens in diverse cancers and found that SETD4 expression correlated significantly positively with neoantigens in THYM, HNSC, MESO, TGCT, KIRP, and TAAD and negatively in UCS, KICH, CHOL, THCA, UVM, LUAD, BRCA, GBM, LIHC, SARC, and BLCA (Figure 6G).